A Comparative Clinical Study To Evaluate The Efficacy Of Vamana Karma And Edgajadi Lepa In The Management Of Vicharchika With Special Reference To Eczema.
试验速览
- 阶段
- 3 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 60
- 试验地点
- 1
- 主要终点
- Decrease in signs and symptoms.
研究概览
简要总结
In this part of study , literary review about disease Vicharchika will be collected from classical text of Ayurveda, thesis of previous research , scientific journals, periodical magazines, monographs and other available sources. Similarly modern review of the disease will be collected from modern medicine books and various website on internet and these will be properly compiled, analysed, classified and then will be presented in arranged manner. Patients will be randomly selected from OPD and IPD of Department of Panchakarma, Government P.G. Ayurveda College and Hospital, Varanasi.
The present study will be carried out in two groups, each group consisting of 30 patients.
Group A : In this group each patient will be subjected for Vamana Karma after Snehapana with Panchatikta Ghrita.
Follow up- 1st follow up on 20th day
2nd follow up on 30th day
Group B : In this group patients will be administered with Edgajadi Lepa locally for 30 days
Dose : Atleast 10gm to be applied locally Once a day.
Follow up - 1st follow up on 20th day
- 2nd follow up on 30th day
Duration of study- 30 days
研究设计
- 研究类型
- Interventional
- 分配方式
- Coin toss, Lottery, toss of dice, shuffling cards etc
- 盲法
- None
入排标准
- 年龄范围
- 18.00 Year(s) 至 60.00 Year(s)（—）
- 性别
- All
入选标准
- •Age 18-60 years.
- •Patient presenting with Cardinal symptoms of Vicharchika.i.e. Kandu, Pidika , Shyavata and srava.
- •3.Symptoms of eczema like itch, dryness, inflamed skin, oozing or crusting.
- •4.Patient voluntarily willing to participate in the trial.
- •â€¢ Immunosuppressive drug, corticosteroid as well as other modern medicine if any will be tapped gradually with a complete washout period of two week.
- •â€¢ Chronicity of Vicharchika minimum 6 months to maximum 10 years.
- •â€¢ Patient Indicated for Vamana.
排除标准
- •1.Patient unwilling to participate in the trial.
- •2.Patient having complication like Severe Renal disease, Severe hypertension, Ischemic Heart Disease , Neuropathy, Dyslipidemia etc.
- •4.Patient associated with any immunocompromised disease like AIDS, tuberculosis etc.
- •5.Patient having BMI index above
- •6.Patient Contraindicated for Vamana as per Samhita.
结局指标
主要结局
Decrease in signs and symptoms.
时间窗: 20 days
次要结局
- Complete relief in sign & symptoms.(30th day)
研究者
Dr Abhishek Kanojia
Government P.G. Ayurveda College and Hospital Varanasi